---
title: Newsroom | COVID-19 (3)
description: COVID-19 |  (3)
---

[![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/)

- [Newsroom](https://news.lifesciencenewswire.com/newsroom)
- [Back to the main site](https://lifesciencenewswire.com/)

![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1")

# Newsroom

#### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow")

#### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg)

![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg)

### Choose a Category

- [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture)
- [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai)
- [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry)
- [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing)
- [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)
- [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing)
- [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology)
- [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture)
- [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)
- [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research)
- [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)
- [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it)
- [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)
- [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)
- [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory)
- [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology)
- [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)
- [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment)
- [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients)
- [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage)
- [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry)
- [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory)
- [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science)
- [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare)
- [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)
- [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science)
- [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing)
- [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science)
- [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)
- [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control)
- [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging)
- [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech)
- [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics)
- [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology)
- [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma)
- [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy)
- [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research)
- [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary)
- [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water)

See all

### Subscribe to Email Updates

<https://news.lifesciencenewswire.com/newsroom/leinco-technologies-inc.-and-la-jolla-institute-for-immunology-announce-license-agreement-to-develop-novel-covid-19-diagnostic-tools>

 Categories: [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Microbiology & Infection Control](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control)

#### [Leinco Technologies, Inc. and La Jolla Institute for Immunology announce license agreement to develop novel COVID-19 diagnostic tools](https://news.lifesciencenewswire.com/newsroom/leinco-technologies-inc.-and-la-jolla-institute-for-immunology-announce-license-agreement-to-develop-novel-covid-19-diagnostic-tools)

 March 9, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/leinco-technologies-inc.-and-la-jolla-institute-for-immunology-announce-license-agreement-to-develop-novel-covid-19-diagnostic-tools)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/leinco-technologies-inc.-and-la-jolla-institute-for-immunology-announce-license-agreement-to-develop-novel-covid-19-diagnostic-tools#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 9, 2021, 1:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/atik-cameras-supports-the-covid-19-fight-with-wide-range-of-aavanced-imaging-solutions-for-use-with-pcr-instruments>

 Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Microscopy & Imaging](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)

#### [Atik Cameras supports the COVID-19 fight with wide range of Aavanced imaging solutions for use with PCR instruments](https://news.lifesciencenewswire.com/newsroom/atik-cameras-supports-the-covid-19-fight-with-wide-range-of-aavanced-imaging-solutions-for-use-with-pcr-instruments)

 February 25, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/atik-cameras-supports-the-covid-19-fight-with-wide-range-of-aavanced-imaging-solutions-for-use-with-pcr-instruments)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/atik-cameras-supports-the-covid-19-fight-with-wide-range-of-aavanced-imaging-solutions-for-use-with-pcr-instruments#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 25, 2021, 2:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/uk-healthcare-pavilion-brings-together-the-uks-healthcare-and-life-sciences-sector-for-the-first-time>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)

#### [UK Healthcare Pavilion brings together the UK’s healthcare and life sciences sector for the first time](https://news.lifesciencenewswire.com/newsroom/uk-healthcare-pavilion-brings-together-the-uks-healthcare-and-life-sciences-sector-for-the-first-time)

 February 22, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/uk-healthcare-pavilion-brings-together-the-uks-healthcare-and-life-sciences-sector-for-the-first-time)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/uk-healthcare-pavilion-brings-together-the-uks-healthcare-and-life-sciences-sector-for-the-first-time#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 22, 2021, 1:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/anteotechs-anteobind-technology-supports-first-of-its-kind-covid-19-home-test>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)

#### [AnteoTech’s AnteoBind™ technology supports first-of-its-kind COVID-19 home test](https://news.lifesciencenewswire.com/newsroom/anteotechs-anteobind-technology-supports-first-of-its-kind-covid-19-home-test)

 February 15, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/anteotechs-anteobind-technology-supports-first-of-its-kind-covid-19-home-test)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/anteotechs-anteobind-technology-supports-first-of-its-kind-covid-19-home-test#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 15, 2021, 2:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/theravectys-announces-20m-funding-round>

 Categories: [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Theravectys announces $20M funding round](https://news.lifesciencenewswire.com/newsroom/theravectys-announces-20m-funding-round)

 February 11, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/theravectys-announces-20m-funding-round)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/theravectys-announces-20m-funding-round#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 11, 2021, 2:29:35 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/medics.academy-and-ethiopian-medical-womens-association-to-address-health-worker-shortfall-and-strengthen-women-physician-leaders-across-ethiopia>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Hospital Management](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)

#### [Medics.Academy and Ethiopian Medical Women’s Association to address health worker shortfall and strengthen women physician leaders across Ethiopia](https://news.lifesciencenewswire.com/newsroom/medics.academy-and-ethiopian-medical-womens-association-to-address-health-worker-shortfall-and-strengthen-women-physician-leaders-across-ethiopia)

 February 8, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/medics.academy-and-ethiopian-medical-womens-association-to-address-health-worker-shortfall-and-strengthen-women-physician-leaders-across-ethiopia)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/medics.academy-and-ethiopian-medical-womens-association-to-address-health-worker-shortfall-and-strengthen-women-physician-leaders-across-ethiopia#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 8, 2021, 1:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/syntekabio-and-hanmi-science-join-forces-to-co-develop-new-promising-covid-19-treatments-using-drug-repurposing-technologies>

 Categories: [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Syntekabio and Hanmi Science join forces to co-develop new promising COVID-19 treatments using drug repurposing technologies](https://news.lifesciencenewswire.com/newsroom/syntekabio-and-hanmi-science-join-forces-to-co-develop-new-promising-covid-19-treatments-using-drug-repurposing-technologies)

 January 19, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/syntekabio-and-hanmi-science-join-forces-to-co-develop-new-promising-covid-19-treatments-using-drug-repurposing-technologies)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/syntekabio-and-hanmi-science-join-forces-to-co-develop-new-promising-covid-19-treatments-using-drug-repurposing-technologies#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 19, 2021, 2:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/the-biotech-company-baseclick-gmbh-launched-a-new-and-highly-efficient-method-for-sars-cov-2-mutation-analysis>

 Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)

#### [The biotech company baseclick GmbH launched a new and highly efficient method for SARS-CoV-2 mutation analysis](https://news.lifesciencenewswire.com/newsroom/the-biotech-company-baseclick-gmbh-launched-a-new-and-highly-efficient-method-for-sars-cov-2-mutation-analysis)

 January 19, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/the-biotech-company-baseclick-gmbh-launched-a-new-and-highly-efficient-method-for-sars-cov-2-mutation-analysis)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/the-biotech-company-baseclick-gmbh-launched-a-new-and-highly-efficient-method-for-sars-cov-2-mutation-analysis#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 19, 2021, 1:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/biotech-team-develops-elisa-protocol-for-covid-19-igg-antibody-detection>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)

#### [Biotech team develops ELISA protocol for COVID-19 IgG antibody detection](https://news.lifesciencenewswire.com/newsroom/biotech-team-develops-elisa-protocol-for-covid-19-igg-antibody-detection)

 January 6, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/biotech-team-develops-elisa-protocol-for-covid-19-igg-antibody-detection)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/biotech-team-develops-elisa-protocol-for-covid-19-igg-antibody-detection#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 6, 2021, 12:00:00 PM

- [Tweet](https://twitter.com/share)

[Previous](https://news.lifesciencenewswire.com/newsroom/tag/covid-19/page/2) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/covid-19/page/4)

##### Browse more news

## Recent releases

<https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility>

#### [Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI f...](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility)

 October 22, 2026

A first for both organisations: the first implantable device built by the UK’s national active implant manufacturing facility is Ceryx’s bioelectronic...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility)

<https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance>

#### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance)

 October 6, 2026

Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance)

<https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development>

#### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

 October 5, 2026

Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development)

![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse")

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225 

#### Useful information

- [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/)
- [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions)
- [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)